{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:59:32Z","timestamp":1763755172724,"version":"3.45.0"},"reference-count":10,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Journal of Oncology Nursing"],"published-print":{"date-parts":[[2006,10,1]]},"DOI":"10.1188\/06.cjon.565-566","type":"journal-article","created":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T11:00:34Z","timestamp":1159959634000},"page":"565-566","source":"Crossref","is-referenced-by-count":5,"title":["Implications of Androgen-Deprivation Therapy in Patients With Prostate Cancer: A Case Study"],"prefix":"10.1188","volume":"10","author":[{"given":"Catherine C.","family":"Burke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Doyle-Lindrud","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2007,1,2]]},"reference":[{"key":"E00001","doi-asserted-by":"crossref","unstructured":"Agarwal, M.M., Khandelwal, N., Mandal, A.K., Rana, S.V., Gupta, V., Chandra Mahon, V., et al. (2005). Factors affecting bone mineral density in patients with prostate carcinoma before and after orchiectomy. <i>Cancer, 103<\/i>, 2042-2052.","DOI":"10.1002\/cncr.21047"},{"key":"E00002","doi-asserted-by":"crossref","unstructured":"Diamond, T., Campbell, J., Bryant, C., & Lynch, W. (1998). The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: Longitudinal evaluation and response to intermittent cyclic etidronate therapy. <i>Cancer, 83<\/i>, 1561-1566.","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1561::AID-CNCR11>3.0.CO;2-Z"},{"key":"E00003","doi-asserted-by":"crossref","unstructured":"Diamond, T.H., Bucci, J., Kersley, J.H., Aslan, P., Lynch, W.B., & Bryant, C. (2004). Osteoporosis and spinal fractures in men with prostate cancer: Risk factors and effects of androgen deprivation therapy. <i>Journal of Urology, 172<\/i>, 529-532.","DOI":"10.1097\/01.ju.0000130508.61020.66"},{"key":"E00004","doi-asserted-by":"crossref","unstructured":"Katz, H. (2005). Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: A report of three cases. <i>Journal of Endontics, 31<\/i>, 831-834.","DOI":"10.1097\/01.don.0000186481.96169.cd"},{"key":"E00005","doi-asserted-by":"crossref","unstructured":"Marx, R.E. (2003). Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. <i>Journal of Oral and Maxillofacial Surgery, 61<\/i>, 1115-1117.","DOI":"10.1016\/S0278-2391(03)00720-1"},{"key":"E00006","doi-asserted-by":"crossref","unstructured":"Migliorati, C.A., Casiglia, J., Epstein, J., Jacobsen, P.L., Siegel, M.A., & Woo, S.B. (2005). Managing the care of patients with bisphosphonate-associated osteonecrosis: An American Academy of Oral Medicine position paper. <i>Journal of the American Dental Association, 136<\/i>, 1658-1668.","DOI":"10.14219\/jada.archive.2005.0108"},{"key":"E00007","doi-asserted-by":"crossref","unstructured":"Migliorati, C.A., Siegel, M.A., & Elting, L.S. (2006). Bisphosphonate-associated osteonecrosis: A long-term complication of bisphosphonate treatment. <i>Lancet Oncology, 7<\/i>, 508-514.","DOI":"10.1016\/S1470-2045(06)70726-4"},{"key":"E00008","doi-asserted-by":"crossref","unstructured":"Olson, K.B., Hellie, C.M., & Pienta, K.J. (2005). Osteonecrosis of jaw in patients with hormone-refractory prostate cancer treated with zoledronic acid. <i>Urology, 66<\/i>, 658.","DOI":"10.1016\/j.urology.2005.03.028"},{"key":"E00009","doi-asserted-by":"crossref","unstructured":"Saad, F., Gleason, D.M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., et al. (2002). A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. <i>Journal of the National Cancer Institute, 94<\/i>, 1458-1468.","DOI":"10.1093\/jnci\/94.19.1458"},{"key":"E00010","doi-asserted-by":"crossref","unstructured":"Shahinian, V.B., Kuo, Y.F., Freeman, J.L., & Goodwin, J.S. (2005). Risk of fracture after androgen deprivation for prostate cancer. <i>New England Journal of Medicine, 352<\/i>, 154-164.","DOI":"10.1056\/NEJMoa041943"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/ons.metapress.com\/index\/E656P674V85P8K61.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:51:34Z","timestamp":1763754694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/10\/5\/implications-androgen-deprivation-therapy-patients-prostate-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,1]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,10,1]]}},"alternative-id":["E656P674V85P8K61"],"URL":"https:\/\/doi.org\/10.1188\/06.cjon.565-566","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2006,10,1]]}}}